SUPRAN BRYAN (EVP, CLO and Secretary) sold 12.1% of their position (1.76K shares) of ALNYLAM PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $398.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/6/2026ACC: 0001178670-26-000068
Officer· EVP, CLO and Secretary
Since Mar 2026
-1.76K
Net shares
Net seller
$398.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.76K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.76K
Price / share
$226.88
Trade value
$398.86K
% of position
12.1%
10/2/2026
14.56K→12.81K
Total
Net shares
−1.76K
Net value
-$398.86K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/2/2026 | S · Sale | −1.76K | $226.88 | $398.86K | 12.1% | 14.56K | 12.81K |
| Total | −1.76K | -$398.86K | ||||||
Derivative Transactions0
No derivative transactions reported